Identification of proliferating human anterior pituitary adenoma cells in vitro

Stephen Atkin, Heather E. Burnett, Alexander M. Landolt, Victoria L. Green, Leslie J. Hipkin, Michael C. White

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A method to determine whether dispersed human anterior pituitary adenoma cells proliferate in mixed culture was developed. Fifteen pituitary adenomas were dispersed enzymatically to single cells, following which twelve were double immunostained after eight days. Proliferating cells were identified immunologically following one hour of bromo-deoxyuridine incorporation. Adenoma cells were subsequently identified with an anti-neuron-specific enolase antibody system. A time course of bromo-deoxyuridine labelling was performed on three nonfunctional adenomas over a four day period, with bromo- deoxyuridine being added to cultures at one hour, 24 hours and four days prior to immunostaining. Double immunolabelled cells were unambiguously identified by a dark brown nucleus surrounded by red cytoplasm. Eight out of 12 pituitary adenomas (two prolactinomas, three nonfunctional, three growth hormone secreting) showed an increased bromo-deoxyuridine labelling index (range 0.1%-1.4%). Bromo-deoxyuridine incorporation over four days showed an increase in bromo-deoxyuridine from 0.02%, 0.03% and 3.3% at one hour to 10.1%, 1.3% and 5.0% at four days, respectively, but evidence of mitosis was scant. This study shows that pituitary adenomas may proliferate in vitro and that this double immunostaining method may be used as an in vitro proliferation assay in a mixed cell population.

Original languageEnglish
Pages (from-to)420-425
Number of pages6
JournalNeurological Research
Volume19
Issue number4
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Forensic Anthropology
Deoxyuridine
Pituitary Neoplasms
Adenoma
Red Nucleus
Prolactinoma
Phosphopyruvate Hydratase
Mitosis
Growth Hormone
In Vitro Techniques
Cytoplasm
Antibodies
Population

Keywords

  • Anterior pituitary adenoma
  • Bromo- deoxyuridine
  • Immunocytochemistry
  • Proliferation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Atkin, S., Burnett, H. E., Landolt, A. M., Green, V. L., Hipkin, L. J., & White, M. C. (1997). Identification of proliferating human anterior pituitary adenoma cells in vitro. Neurological Research, 19(4), 420-425.

Identification of proliferating human anterior pituitary adenoma cells in vitro. / Atkin, Stephen; Burnett, Heather E.; Landolt, Alexander M.; Green, Victoria L.; Hipkin, Leslie J.; White, Michael C.

In: Neurological Research, Vol. 19, No. 4, 1997, p. 420-425.

Research output: Contribution to journalArticle

Atkin, S, Burnett, HE, Landolt, AM, Green, VL, Hipkin, LJ & White, MC 1997, 'Identification of proliferating human anterior pituitary adenoma cells in vitro', Neurological Research, vol. 19, no. 4, pp. 420-425.
Atkin S, Burnett HE, Landolt AM, Green VL, Hipkin LJ, White MC. Identification of proliferating human anterior pituitary adenoma cells in vitro. Neurological Research. 1997;19(4):420-425.
Atkin, Stephen ; Burnett, Heather E. ; Landolt, Alexander M. ; Green, Victoria L. ; Hipkin, Leslie J. ; White, Michael C. / Identification of proliferating human anterior pituitary adenoma cells in vitro. In: Neurological Research. 1997 ; Vol. 19, No. 4. pp. 420-425.
@article{be42172d3a7a470fb40764e8214c997a,
title = "Identification of proliferating human anterior pituitary adenoma cells in vitro",
abstract = "A method to determine whether dispersed human anterior pituitary adenoma cells proliferate in mixed culture was developed. Fifteen pituitary adenomas were dispersed enzymatically to single cells, following which twelve were double immunostained after eight days. Proliferating cells were identified immunologically following one hour of bromo-deoxyuridine incorporation. Adenoma cells were subsequently identified with an anti-neuron-specific enolase antibody system. A time course of bromo-deoxyuridine labelling was performed on three nonfunctional adenomas over a four day period, with bromo- deoxyuridine being added to cultures at one hour, 24 hours and four days prior to immunostaining. Double immunolabelled cells were unambiguously identified by a dark brown nucleus surrounded by red cytoplasm. Eight out of 12 pituitary adenomas (two prolactinomas, three nonfunctional, three growth hormone secreting) showed an increased bromo-deoxyuridine labelling index (range 0.1{\%}-1.4{\%}). Bromo-deoxyuridine incorporation over four days showed an increase in bromo-deoxyuridine from 0.02{\%}, 0.03{\%} and 3.3{\%} at one hour to 10.1{\%}, 1.3{\%} and 5.0{\%} at four days, respectively, but evidence of mitosis was scant. This study shows that pituitary adenomas may proliferate in vitro and that this double immunostaining method may be used as an in vitro proliferation assay in a mixed cell population.",
keywords = "Anterior pituitary adenoma, Bromo- deoxyuridine, Immunocytochemistry, Proliferation",
author = "Stephen Atkin and Burnett, {Heather E.} and Landolt, {Alexander M.} and Green, {Victoria L.} and Hipkin, {Leslie J.} and White, {Michael C.}",
year = "1997",
language = "English",
volume = "19",
pages = "420--425",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - Identification of proliferating human anterior pituitary adenoma cells in vitro

AU - Atkin, Stephen

AU - Burnett, Heather E.

AU - Landolt, Alexander M.

AU - Green, Victoria L.

AU - Hipkin, Leslie J.

AU - White, Michael C.

PY - 1997

Y1 - 1997

N2 - A method to determine whether dispersed human anterior pituitary adenoma cells proliferate in mixed culture was developed. Fifteen pituitary adenomas were dispersed enzymatically to single cells, following which twelve were double immunostained after eight days. Proliferating cells were identified immunologically following one hour of bromo-deoxyuridine incorporation. Adenoma cells were subsequently identified with an anti-neuron-specific enolase antibody system. A time course of bromo-deoxyuridine labelling was performed on three nonfunctional adenomas over a four day period, with bromo- deoxyuridine being added to cultures at one hour, 24 hours and four days prior to immunostaining. Double immunolabelled cells were unambiguously identified by a dark brown nucleus surrounded by red cytoplasm. Eight out of 12 pituitary adenomas (two prolactinomas, three nonfunctional, three growth hormone secreting) showed an increased bromo-deoxyuridine labelling index (range 0.1%-1.4%). Bromo-deoxyuridine incorporation over four days showed an increase in bromo-deoxyuridine from 0.02%, 0.03% and 3.3% at one hour to 10.1%, 1.3% and 5.0% at four days, respectively, but evidence of mitosis was scant. This study shows that pituitary adenomas may proliferate in vitro and that this double immunostaining method may be used as an in vitro proliferation assay in a mixed cell population.

AB - A method to determine whether dispersed human anterior pituitary adenoma cells proliferate in mixed culture was developed. Fifteen pituitary adenomas were dispersed enzymatically to single cells, following which twelve were double immunostained after eight days. Proliferating cells were identified immunologically following one hour of bromo-deoxyuridine incorporation. Adenoma cells were subsequently identified with an anti-neuron-specific enolase antibody system. A time course of bromo-deoxyuridine labelling was performed on three nonfunctional adenomas over a four day period, with bromo- deoxyuridine being added to cultures at one hour, 24 hours and four days prior to immunostaining. Double immunolabelled cells were unambiguously identified by a dark brown nucleus surrounded by red cytoplasm. Eight out of 12 pituitary adenomas (two prolactinomas, three nonfunctional, three growth hormone secreting) showed an increased bromo-deoxyuridine labelling index (range 0.1%-1.4%). Bromo-deoxyuridine incorporation over four days showed an increase in bromo-deoxyuridine from 0.02%, 0.03% and 3.3% at one hour to 10.1%, 1.3% and 5.0% at four days, respectively, but evidence of mitosis was scant. This study shows that pituitary adenomas may proliferate in vitro and that this double immunostaining method may be used as an in vitro proliferation assay in a mixed cell population.

KW - Anterior pituitary adenoma

KW - Bromo- deoxyuridine

KW - Immunocytochemistry

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=0030795803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030795803&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 420

EP - 425

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 4

ER -